Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial.

Yamakage, Hajime; Tanaka, Masashi; Inoue, Takayuki; Odori, Shinji; Kusakabe, Toru; Satoh-Asahara, Noriko

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial.

Yamakage, Hajime; Tanaka, Masashi; Inoue, Takayuki; Odori, Shinji; Kusakabe, Toru; Satoh-Asahara, Noriko.

Afiliação

Yamakage H; Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Tanaka M; Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Inoue T; Department of Physical Therapy, Health Science University, Yamanashi, Japan.
Odori S; Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Kusakabe T; Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Satoh-Asahara N; Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

J Diabetes Investig ; 11(3): 653-661, 2020 May.

Article em En | MEDLINE | ID: mdl-31721467

Assuntos

Compostos Benzidrílicos/uso terapêutico; Diabetes Mellitus Tipo 2/tratamento farmacológico; Fatores de Crescimento de Fibroblastos/sangue; Glucosídeos/uso terapêutico; Monocinas/sangue; Músculo Esquelético/patologia; Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico; Idoso; Povo Asiático; Diabetes Mellitus Tipo 2/sangue; Diabetes Mellitus Tipo 2/patologia; Feminino; Humanos; Japão; Masculino; Pessoa de Meia-Idade; Resultado do Tratamento

Palavras-chave

Muscle mass; Sodium-glucose cotransporter 2 inhibitor; Type 2 diabetes

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Monocinas / Músculo Esquelético / Diabetes Mellitus Tipo 2 / Fatores de Crescimento de Fibroblastos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Diabetes Investig Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google